HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Abstract
HLA-DM is essential for editing peptides bound to MHC class II, thus influencing the repertoire of peptides mediating selection and activation of CD4(+) T cells. Individuals expressing HLA-DQ2 or DQ8, and DQ2/8 trans-dimers, have elevated risk for type 1 diabetes (T1D). Cells coexpressing DM with these DQ molecules were observed to express elevated levels of CLIP (Class II associated invariant chain peptide). Relative resistance to DM-mediated editing of CLIP was further confirmed by HPLC-MS/MS analysis of eluted peptides, which also demonstrated peptides from known T1D-associated autoantigens, including a shared epitope from ZnT8 that is presented by all four major T1D-susceptible DQ molecules. Assays with purified recombinant soluble proteins confirmed that DQ2-CLIP complexes are highly resistant to DM editing, whereas DQ8-CLIP is partially sensitive to DM, but with an apparent reduction in catalytic potency. DM sensitivity was enhanced in mutant DQ8 molecules with disruption of hydrogen bonds that stabilize DQ8 near the DM-binding region. Our findings show that T1D-susceptible DQ2 and DQ8 share significant resistance to DM editing, compared with control DQ molecules. The relative resistance of the T1D-susceptible DQ molecules to DM editing and preferential presentation of T1D-associated autoantigenic peptides may contribute to the pathogenesis of T1D.
AuthorsZemin Zhou, Eduardo Reyes-Vargas, Hernando Escobar, Brant Rudd, Alan L Rockwood, Julio C Delgado, Xiao He, Peter E Jensen
JournalEuropean journal of immunology (Eur J Immunol) Vol. 46 Issue 4 Pg. 834-45 (Apr 2016) ISSN: 1521-4141 [Electronic] Germany
PMID26707565 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Antigens, Differentiation, B-Lymphocyte
  • Autoantigens
  • HLA-D Antigens
  • HLA-DM antigens
  • HLA-DQ Antigens
  • HLA-DQ2 antigen
  • HLA-DQ8 antigen
  • Histocompatibility Antigens Class II
  • invariant chain
Topics
  • Amino Acid Sequence
  • Antigens, Differentiation, B-Lymphocyte (immunology)
  • Autoantigens (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • Cell Line
  • Diabetes Mellitus, Type 1 (immunology)
  • HEK293 Cells
  • HLA-D Antigens (immunology)
  • HLA-DQ Antigens (genetics, immunology)
  • Histocompatibility Antigens Class II (immunology)
  • Humans
  • Lymphocyte Activation (immunology)
  • Molecular Sequence Data

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: